The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for 5 SSPs. The following SSPs have been further extended to Friday 27 January 2023. SSP Expiry Date Supporting Information SSP029 Sandrena® 0.5mg and 1mg gel sachets – restriction 27 January 2023 SSP029 guide SSP030 Sandrena® 0.5mg
Read morePSNC has published new guidance to help community pharmacy contractors to complete the 2022/23 Data Security and Protection Toolkit. The Toolkit is used to make a pharmacy’s information governance (IG) declaration and must be completed by Friday 30th June 2023. We recommend that contractors complete the Toolkit as soon as possible. We collaborated with NHS Digital to
Read moreThe Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Lenzetto® 1.53mg/dose transdermal spray is now available to meet normal demand. As a result the following Serious Shortage Protocols, will expire at 23.59pm on Friday 13 January 2023. After this date, any prescriptions for Lenzetto® 1.53mg/dose transdermal spray must be dispensed
Read moreCLMR number: CLMR (23)A/01 Date issued: 12th January 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led medicines recall for: Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection (Mawdsley-Brooks & Company Limited). Fluphenazin-neuraxpharm® D 100 mg/ml Solution for Injection [unlicensed medicine] Batch number Expiry Date Pack Size First Distributed 200686
Read moreWork to develop a new vision and strategic options for community pharmacy is now well underway, being led by Nuffield Trust and The King’s Fund. An online consultation to gather views from the sector closed last month with the submissions now being collated prior to being passed to Nuffield Trust and The King’s Fund. Engagement
Read morePSNC and other pharmacy leaders have warned the Government about a lack of engagement with stakeholders around the development of its long-term workforce plan. A joint letter signed by representatives from 14 pharmacy organisations has called for reassurance that the workforce plan, expected by April 2023, will cover the entirety of the pharmacy workforce across
Read moreThe Government’s scheme providing free personal protective equipment (PPE) to health and care providers, including community pharmacies in England, has been extended for another year. The Department of Health and Social Care (DHSC) has announced that it will continue to supply all categories of PPE, free of charge, for frontline health and social care staff
Read moreThe NHS Business Services Authority (NHSBSA) has published the questions which will be included in the 2022/23 Pharmacy Quality Scheme (PQS) declaration so community pharmacy contractors can view these ahead of making their declaration. The questions are available on the NHSBSA PQS hub page; contractors should scroll down to the ‘Declaration questions’ section where they can
Read moreClass 4 Medicines Defect Information: Bylvay 1200 micrograms Hard Capsules (Albireo AB) Drug alert number: EL (23)A/01 Date issued: 3 January 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Bylvay 1200 micrograms Hard Capsules, PLGB 36216/0004 Batch number Expiry date Pack size First distributed
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Norditropin (somatropin) Flexpro® 10mg/1.5ml and Norditropin (somatropin) NordiFlex® 5mg/1.5ml, 10mg/1.5ml and 15mg/1.5ml solution for injection pre-filled pens. MSN/2023/001 Tier 2 – medium impact Date of issue 3rd January 2023 Norditropin (somatropin) Flexpro® 10mg pen is out of stock until early February
Read more
